The detection rate of PTCH1 variants in clinically diagnosed NBCCS was reported to range from 40 to 85%, while SUFU variants were found in 5.3% of all NBCCS patients6. The gene discussed is SUFU; the disease is nevoid basal cell carcinoma syndrome.